The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders
https://doi.org/10.37489/2588-0519-2020-3-85-92
Abstract
Actuality. Drug safety issues in patients with psychiatric disorders are relevant due to specifics of clinical pharmacology of the medicinal products used, possible treatment-resistance of mental illnesses and concomitant use of multiple antipsychotic drugs. One of the aspects of treatment safety is a prediction of drug-drug interactions.
The aim of the study was to analyze potential drug-drug interactions in patients with psychiatric disorders.
Materials and methods. The study enrolled 500 patients with psychiatric disorders in two age-related groups. Drug therapy was analyzed to reveal potential cases of drug-drug interactions.
Results. A total of 1 031 cases of the use of drug combinations leading to drug-drug interactions of various clinical significance were revealed in 72.4 % of patients. There were significant differences between two age-related groups in respect of the specifics of medications use and clinical significance of drug combinations.
Conclusion. Prediction of drug-drug interactions is likely to ensure improved drug safety in patients with psychiatric disorders.
About the Authors
O. O. Kirilochev
Federal State Budgetary Educational Institution of Higher Education «Astrakhan State Medical University» of the Ministry of Healthcare of the Russian Federation;
Astrakhan Regional Clinical Psychiatric Hospita
Russian Federation
Russian Federation
Kirilochev Oleg O. - PhD of Medicine, Associate Professor of the Department of Clinical Pharmacology
SPIN code: 2050-2190
Astrakhan
A. R. Umerova
Federal State Budgetary Educational Institution of Higher Education «Astrakhan State Medical University» of the Ministry of Healthcare of the Russian Federation,
Russian Federation
Russian Federation
Umerova Adelya R. - D. Sci in Medicine, Head of the Department of Clinical Pharmacology
SPIN code: 2050-2190
Astrakhan
References
1. Hahn M, Reiff J, Hiemke C, Braus D. Drug-Drug-Interactions in Psychiatry. Psychiatr Prax. 2013;40(03):154—158. DOI:10.1055/s-0032-1332831
2. Castilho ECD, Reis AMM, Borges TL, Siqueira LDC, Miasso AI. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil. J Psychiatr Ment Health Nurs. 2018;25(1):3—13. DOI:10.1111/jpm.12431
3. Otdelenov VA, Novakova AI, Karasev AV, et al. Estimation of the incidence of potentially significant drug-drug interactions in patients with polypharmacy in the general hospital. Klinicheskaya farmakologiya i terapiya. 2012;21(5):3—13. (In Russ).
4. Murtaza G, Khan MYG, Azhar S, et al. Assessment of potential drug- drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2015;24(2):220—225. DOI:10.1016/j.jsps.2015.03.009
5. Astrand B. Avoiding Drug-Drug Interactions. Chemotherapy. 2009;55(4):215—220. DOI:10.1159/000218100
6. Spina E, Hiemke C, de Leon J. Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2016;12(4):407—422. DOI:10 .1517/17425255.2016.1154043
7. de Leon J. Have we successfully implemented CYP2D6 genotyping in psychiatry? Expert Opin Drug Metab Toxicol. 2017;13(12):1201—1203. DOI: 10.1080/17425255.2017.1406920
8. Correll CU, Rummel-Kluge C, Corves C, et al. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull. 2009;35(2):443—457. DOI:10.1093/schbul/sbn018
9. Tranulis C, Skalli L, Lalonde P, et al. Benefits and Risks of AntipsychoticPolypharmacy. Drug Saf. 2008;31(1):7—20. DOI: 10.2165/00002018-200831010-00002
10. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15—19. DOI:10.1136/bmj.329.7456.15
11. Otdelenov V, Sychev D, Kleimenova E, et al. Automated prediction of drug interactions on the basis of an analysis of drug prescriptions. Vrach. 2013;(11):78—82. (In Russ).
12. Morte-Romea E, Luque-Gomez P, Arenere-Mendoza M, et al. Performance Assessment of Software to Detect and Assist Prescribers with Antimicrobial Drug Interactions: Are all of them Created Equal? Antibiot (Basel, Switzerland). 2020;9(1). DOI:10.3390/antibiotics9010019
13. Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257—263. DOI:10.4103/2279-042X.192461
14. Anthony Berauk VL, Murugiah MK, Soh YC, et al. Mobile Health Applications for Caring of Older People: Review and Comparison. Innov Regul Sci. 2018;52(3):374—382. DOI:10.1177/2168479017725556
15. Woosley RL, Romero K, Heise CW, et al. Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death. Drug Saf. 2017;40(6):465—474. DOI:10.1007/s40264-017-0519-0
16. Kirilochev OO, Dorfman IP, Umerova AR, Bataeva SE. Potential drug- drug interactions in the psychiatric hospital: Frequency analysis. Res Results Pharmacol. 2019;5(4):1—6. DOI:10.3897/rrpharmacology.5.39681
17. Rossiiskoe obshchestvo psikhiatrov. Shizofreniya (F20) (proekt klinicheskikh rekomendatsii). 2019. (In Russ). Available from:: https://psychiatr.ru/download/4244?view=1&name=%D0%9A%D0%A0_+%D0%A8%D0%B8%D0%B7%D0%BE%D1%84%D1%80%D0%B5%D0%BD%D0%B8%D1%8F+25-11.pdf. Ссылка активна на 05.06.2020.
18. Mareev VY, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8— 158. (In Russ). DOI:10.18087/cardio.2475
Review
For citations:
Kirilochev O.O., Umerova A.R. The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(3):85-92. (In Russ.) https://doi.org/10.37489/2588-0519-2020-3-85-92
Views:
1285
Email this article 